mRNA Vaccine Technology Beyond COVID-19
Background/Objectives: Since their approval in early 2020, mRNA vaccines have gained significant attention since the COVID-19 pandemic as a potential therapeutic approach to tackle several infectious diseases. This article aims to review the current state of mRNA vaccine technology and its use again...
Saved in:
| Main Authors: | Sola Oloruntimehin, Florence Akinyi, Michael Paul, Olumuyiwa Ariyo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/6/601 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01) -
A Systematic Review of Clinical Trials Using mRNA Vaccines for Infectious Diseases other than COVID-19
by: Athina Sofroniou, et al.
Published: (2025-07-01) -
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
by: Kai Yuan Leong, et al.
Published: (2025-03-01) -
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
by: Dariush Haghmorad, et al.
Published: (2025-03-01) -
Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection
by: Aseno Sakhrie, et al.
Published: (2025-05-01)